Parmax Pharma Ltd — Insider Trading, 29-06-2026: Insider Trading / SAST

Parmax Pharma Limited has closed its trading window for Designated Persons starting July 1st. This is a standard measure taken in anticipation of announcing the financial results for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after these financial results are officially declared. A specific date for the upcoming Board Meeting to consider these results will be communicated in due course. This action ensures fair trading practices and prevents insiders from trading on unpublished price-sensitive information before the results are public.